NIOX Group Plc

NIOX provides the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD globally. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. Incorporated in 2006 and headquartered in Oxford, the United Kingdom, NIOX was formerly known as Circassia Group Plc before rebranding in September 2022.